SPONSOR
Suzhou Alphamab Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 1
Clinical Trials by Suzhou Alphamab Co., Ltd.
NCT07201467 Phase 1, Phase 2
Recruiting
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
End-Stage Renal Disease Requiring Haemodialysis
NCT07191899 Phase 1
Recruiting
To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension
Hypertension
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology